NCT02682238 - A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 8, 2016

Primary Completion Date

July 14, 2016

Study Completion Date

October 4, 2016

Conditions

Hyperhidrosis

Interventions

DRUG

BBI-4000, 15%

OTHER

Vehicle gel

Trial Locations (5)

Virginia Clinical Research, Inc., Norfolk

International Dermatology Research, Inc., Miami

Shideler Clinical Research Center, Carmel

Saint Louis University Dermatology, St Louis

TCR Medical Corporation, San Diego